Tatyana Zvyaga
Papers
2
Total Citations
171
H-Index
2
About
Tatyana Zvyaga is a leading figure in pharmaceutical profiling and drug metabolism, whose work has fundamentally advanced the efficiency of early-stage drug discovery. Her primary research focuses on developing high-throughput, automated methods to assess the metabolic stability of drug candidates—a critical determinant of a compound's viability. Her most influential contribution is a seminal 2008 paper (134 citations) detailing an automated liquid chromatography-mass spectrometry (LC-MS) process that measures metabolic stability half-life and intrinsic clearance via substrate depletion. This work, alongside her earlier 2007 paper (37 citations) introducing the "MetFast" assay, revolutionized the field by replacing slow, manual processes with rapid, robotic systems. These innovations allow for the simultaneous incubation of compounds with liver microsomes and automated sampling, enabling the swift, reliable profiling of thousands of candidates. By dramatically accelerating the identification of stable, promising leads, Zvyaga’s research has become a cornerstone of modern pharmaceutical property profiling, directly impacting the speed and cost-effectiveness of bringing new drugs to market. Her achievements represent a pivotal shift toward automation in preclinical drug development.
Research Focus
Key Achievements
Top Papers
- 1
- 2